SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses

(2022) Alexandra C. Walls et al.   CELL

Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections

(2022) Sara Terreri et al.   Cell Host & Microbe

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo

(2022) Kenrie P. Y. Hui et al.   NATURE

The T cell immune response against SARS-CoV-2

(2022) Paul Moss   NATURE IMMUNOLOGY

Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern

(2022) Paul R. Wratil et al.   NATURE MEDICINE

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons

(2022) Annika Rössler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants

(2022) David W. Eyre et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel

(2022) Ottavia Prunas et al.   SCIENCE

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection

(2022) John P. Evans et al.   Science Translational Medicine

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts

(2022) Rhia Kundu et al.   Nature Communications

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants

(2022) Timothy A. Bates et al.   Science Immunology

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study

(2022) Cristina Menni et al.   LANCET

COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study

(2022) Cristina Menni et al.   LANCET INFECTIOUS DISEASES

Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study

(2022) Daniel J Sheward et al.   LANCET INFECTIOUS DISEASES

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial

(2022) Laurence Chu et al.   NATURE MEDICINE

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

(2022) Nick Andrews et al.   NEW ENGLAND JOURNAL OF MEDICINE

Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors

(2022) Laura Pérez-Alós et al.   Nature Communications

SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after Vaccination

(2022) Jelissa Katharina Peter et al.   Microorganisms

Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response

(2022) Jernej Pušnik et al.   JOURNAL OF VIROLOGY

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

(2021) Jennifer M. Dan et al.   SCIENCE

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

(2021) Jackson S. Turner et al.   NATURE

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

(2021) Moriah Bergwerk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

(2021) Lucie Loyal et al.   SCIENCE

Hybrid immunity

(2021) Shane Crotty   SCIENCE

Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help

(2021) Jernej Pušnik et al.   Cell Reports

Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants

(2021) Emanuele Andreano et al.   NATURE

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

(2021) Einav G. Levin et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers

(2021) Francesca Rovida et al.   Nature Communications

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies

(2021) Daniel M Altmann et al.   Lancet Respiratory Medicine

Evaluation of a COVID-19 Vaccine Campaign and SARS-CoV-2 Infection and Mortality Among Adults Aged 60 Years And Older in a Middle-Income Country

(2021) Alejandro Macchia et al.   JAMA Network Open

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era

(2021) Stephen Y Wang et al.   Lancet Microbe

An interactive web-based dashboard to track COVID-19 in real time

(2020) Ensheng Dong et al.   LANCET INFECTIOUS DISEASES

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

(2020) Edward E. Walsh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection

(2020) Michael W. Russell et al.   Frontiers in Immunology